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topic. Korean clinical trials were done on dyslipidemia(n=2)
and diabetes(n=1). Signiﬁcant adverse effectswere null in clin-
ical studies. Methodological quality of the studies were varied.
Gastrointestinal, antidiabetic, and dermatologic useswere not
mentioned in traditional literature or had very small numbers
of citations. These uses are identiﬁed as potential areas for
reinvestigation and reintroduction to Koreanmedical practice.
Conclusion: There is potential for different uses of Mori
folium in Korean medicine in addition to the current clini-
cal landscape. More clinical research from the Korean medical
point of view is needed.
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Purpose: Saam acupuncture initiated by Saamdoin is
traditional and originative method, which is character-
ized by applying the ﬁve phases theory and mother-child
reinforcement-reduction principle to the selection of acu-
points and needling manipulation. This study was aimed to
summarize and assess the use of acupoint SP3 (Taebaek)
in Saam acupuncture treatment and to further understand
Saam acupuncture in an aspect of the combination of
acupoints.
Methods: We searched the data based on <(Do Hae Kyo
Kam) Sa-Ahm’s acupuncture method> for SP3 used and acu-
point combination including SP3. We carried out frequency
analysis, network analysis, and cluster analysis for quanti-
tative aspect. To understand clinical implication of SP3 with
another acupoint, qualitative and descriptive methods were
also performed.
Results: In our study, SP3 was frequently used for toniﬁca-
tion of lung, spleen, heart, and kidney meridian and sedation
of kidney, heart, and lung meridian. For this, many acu-
points such as LU8, LU9, KI3, HT8, KI7, LU10 and LR1 were
used with SP3. The combination of SP3 and other acupoints
were used to treat stroke, common cold, and pain conditions
including headache, low back pain, respiratory disease as well
as gastroenteric troubles including stomachache, indigestion,
vomiting, and constipation.
Conclusion: To further understand Saam acupuncture, an
understanding of the ﬁve transport points based on ﬁve
elements characters, pathological changes (deﬁciency and
excess) of viscera and bowels, and concept of source point
should be preceded.
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Purpose: With the increased use of herbal medicines,
many patients frequently co-administrated with herbs and
conventional drugs, without being aware of the potential of
herb-drug interactions. In particular, herbal formulas have
the possible to interact with various drugs because they are
composed of multiple active herbs and components. In the
previous study, we demonstrated that co-treatment of tra-
ditional herbal formula Gumiganghwal-tang (GMGHT) and
montelukast reduced the eotaxin production, which more
effective than respectively single treatment of them in IL-
4 and TNF--stimulated human bronchial epithelial cells
(Jeon et al.). Therefore, the present study was carried out
to investigate the possible interactions between GMGHT and
montelukast.
Methods: The inﬂuence of GMGHT on the activities
of human cytochrome P450 (CYP450; CYP1A2, CYP2B6,
CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4) and UDP-
glucuronosyl transferase (UGT; UGT1A1 and UGT2B7),
which are drug-metabolizing enzymes, were assessed
using in vitro ﬂuorescence- and luminescence-based assay,
respectively.
Results: The previous studies demonstrated that CYP3A4
and CYP2C9 was responsible in part for the oxidative
metabolism of montelukast. GMGHT strongly inhibited
CYP1A2 (IC50 = 144.91g/mL), CYP2D6 (IC50 = 80.15g/mL)
and CYP2E1 (IC50 = 105.99g/mL), whereas it relatively weak
inhibited CYP2B6 (IC50 = 544.97g/mL), CYP2C19 (IC50 =
255.82g/mL), CYP3A4 (IC50 = 334.04g/mL), and UGT1A1
(IC50 = 470.55g/mL). On the other hand, GMGHT negligi-
ble inhibited on CYP2C9, with an IC50 value in excess of
1000g/mL, and it had no effect on UGT2B7.
Conclusion: These ﬁndings suggest that co-administration
of GMGHT and montelukast may useful to ameliorate airway
inﬂammatory response, as well as it is unlikely to cause clini-
cally relevant herb-drug interactions. Furthermore, even with
low doses of montelukast can be expected a good therapeutic
effect when montelukast are used in combination with
GMGHT.
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